Skip to main content
Premium Trial:

Request an Annual Quote

Lynx Adds Two Patents to Genomics IP Portfolio

Premium

H

AYWARD, Calif.--Lynx Therapeutics was recently issued a patent broadly covering its use of encoded adaptors in its Massively Parallel Signature Sequencing technology. The company has also acquired an exclusive worldwide license to a molecular tagging technology invented by George Church and Stephen Kieffer-Higgins at Harvard Medical School.

Norrie Russell, Lynx’s CEO, said the company’s intellectual property portfolio now includes 49 patents in the area of genomics, DNA analysis, and DNA chemistry. Said Russell, "Encoded adaptors are a key element of our MPSS technology since they increase the efficiently of the method by almost an order of magnitude." He added that the license to the Harvard technology broadens the reach of Lynx’s existing patents covering its Megaclone technology, which enables simultaneous manipulation and analysis of very complex mixtures of millions of DNA molecules or fragments.

Filed under

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.